Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate 31722-0155
Product NDC
31722-0155- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- May 10, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA213709
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 1.25 mg/1 |
| Amphetamine Sulfate | 1.25 mg/1 |
| Dextroamphetamine Saccharate | 1.25 mg/1 |
| Dextroamphetamine Sulfate | 1.25 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Packaging Options(1)
100 TABLET in 1 BOTTLE (31722-155-01)